title: [Comparison of superselective intraarterial fibrinolysis with conservative therapy. Use in patients with acute non-arteritic central retinal artery occlusion].
abstract: The results of conservative treatment for central retinal artery occlusion (CRAO) vary considerably and although local intraarterial fibrinolysis (LIF) is a promising treatment, outcomes have not been compared in randomized trials. The prospective randomized multicenter study by the European Assessment Group for Lysis in the Eye (EAGLE) is the first clinical trial to compare treatment outcomes of conservative standard treatment (CST) and LIF for acute non-arteritic CRAO. Patients (age 18-75 years) with CRAO present for less than 20 h and best-corrected visual acuity (BCVA) <0.5 logMAR were randomized to either CST or LIF group. Primary endpoint was BCVA after 1 month and secondary endpoint was safety. Mean BCVA (logMAR) improved significantly in both groups and did not differ between the groups. Because of similar efficacy and the higher rate of adverse events in the LIF group the study was halted after the first interim analysis. Due to the similar outcomes of the two therapies and the higher rate of adverse reactions associated with LIF superselective lysis cannot be recommended for the management of acute CRAO.
authors.affiliation: Augenklinik der Ludwig-Maximilians-Universität, Mathildenstraße 8, 80336, München. armin.wolf@med.uni-muenchen.de
authors.forename: A
authors.initials: A
authors.lastname: Wolf
authors.forename: M
authors.initials: M
authors.lastname: Schumacher
authors.forename: A S
authors.initials: AS
authors.lastname: Neubauer
authors.forename: C
authors.initials: C
authors.lastname: Schmoor
authors.forename: C
authors.initials: C
authors.lastname: Gall
authors.forename: B
authors.initials: B
authors.lastname: Jurklies
authors.forename: I
authors.initials: I
authors.lastname: Wanke
authors.forename: L
authors.initials: L
authors.lastname: Solymosi
authors.forename: H
authors.initials: H
authors.lastname: Brückmann
authors.forename: D
authors.initials: D
authors.lastname: Schmidt
authors.forename: N
authors.initials: N
authors.lastname: Feltgen
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001167:Arteritis / Q000150:complications / Q000188:drug therapy; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005858:Germany; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D015356:Retinal Artery Occlusion / Q000188:drug therapy* / Q000209:etiology; D012173:Retinitis / Q000150:complications / Q000188:drug therapy; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
references.citation: Br J Ophthalmol. 2008 May;92(5):588-93
references.pmid: 18441166
references.citation: Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):464-6; author reply 467-70
references.pmid: 17119999
references.citation: Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001989
references.pmid: 19160204
references.citation: Ophthalmology. 1995 Dec;102(12):2029-34; discussion 2034-5
references.pmid: 9098313
references.citation: J Neuroimaging. 2007 Oct;17(4):339-43
references.pmid: 17894624
references.citation: Br J Ophthalmol. 2000 Aug;84(8):914-6
references.pmid: 10906103
references.citation: Arch Ophthalmol. 2003 Oct;121(10):1377-81
references.pmid: 14557172
references.citation: Am J Ophthalmol. 1992 Apr 15;113(4):429-34
references.pmid: 1558118
references.citation: Am J Ophthalmol. 2008 Nov;146(5):700-6
references.pmid: 18718570
references.citation: Br J Ophthalmol. 1980 Dec;64(12):913-7
references.pmid: 7448144
references.citation: Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):950-6
references.pmid: 16372192
references.citation: Am J Ophthalmol. 2008 Nov;146(5):631-4
references.pmid: 18984082
references.citation: J Fr Ophtalmol. 1984;7(11):711-6
references.pmid: 6533162
references.citation: Br J Ophthalmol. 2008 May;92(5):585-7
references.pmid: 18441165
references.citation: Acta Ophthalmol Suppl. 1971;109:1-95
references.pmid: 4334005
references.citation: Stroke. 1992 May;23(5):632-40
references.pmid: 1579958
references.citation: Stroke. 1992 May;23(5):641-5
references.pmid: 1579959
references.citation: Br J Ophthalmol. 1980 Nov;64(11):818-25
references.pmid: 7426553
references.citation: Ophthalmologe. 2006 Oct;103(10):898-900
references.pmid: 16998653
references.citation: Neuroradiology. 1993;35(8):600-5
references.pmid: 8278042
references.citation: Invest Ophthalmol Vis Sci. 1993 Jan;34(1):120-9
references.pmid: 8425819
references.citation: Ophthalmology. 2010 Jul;117(7):1367-75.e1
references.pmid: 20609991
references.citation: Circulation. 2007 May 22;115(20):e478-534
references.pmid: 17515473
references.citation: Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):137-42
references.pmid: 18766368
references.citation: Graefes Arch Clin Exp Ophthalmol. 2009 Apr;247(4):491-4
references.pmid: 18989688
references.citation: Klin Monbl Augenheilkd. 2000 Jul;217(1):30-6
references.pmid: 10949814
references.citation: Exp Eye Res. 2004 Mar;78(3):723-36
references.pmid: 15106952
references.citation: Ophthalmology. 1982 Jan;89(1):14-9
references.pmid: 7070767
references.citation: Am J Ophthalmol. 2005 Sep;140(3):376-91
references.pmid: 16138997